Optimizing treatment with risperidone long acting injections

Warning

This publication doesn't include Faculty of Medicine. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Title in English	Optimalizace léčby dlouhodobě působící injekcí risperidonu
Authors	ČEŠKOVÁ Eva
Year of publication	2012
Type	Article in Periodical
Magazine / Source	Acta Psychiatrica Scandinavica
MU Faculty or unit	Central European Institute of Technology
Citation
Doi	http://dx.doi.org/10.1111/acps.12014
Field	Psychiatry, sexuology
Keywords	risperidone; long acting injection; RLAI; treatment
Attached files	Optimizing_treatment_with_risperidone.pdf
Description	The outcome could be improved by targeting RLAI treatment at specific patient groups and optimizing the dose. RLAI should be quickly titrated to an effective dose in patients known to be responsive to antipsychotic treatment. The high frequency of co medication in our sample indicates a certain level of pharmacoresistance. In spite of this, a significant decrease in concomitant medication was observed. Therapeutic drug monitoring is another possibility for optimizing treatment with RLAI.
Related projects:	The internal organisation and neurobiological mechanisms of functional CNS systems under normal and pathological conditions. CEITEC - Central European Institute of Technology